Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Sep. 30, 2026
shares
| |
| Trading Arrangements, by Individual | |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Dr. Ann S. Blouin [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | Dr. Ann S. Blouin, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on August 27, 2026. Dr. Blouin's 10b5-1 plan provides for the sale of up to 450 shares of the Company's common stock between November 30, 2026 and August 27, 2027. |
| Name | Dr. Ann S. Blouin |
| Title | a member of our Board of Directors |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | August 27, 2026 |
| Expiration Date | August 27, 2027 |
| Arrangement Duration | 270 days |
| Aggregate Available | 450 |
| Chad A. Keetch [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | Chad A. Keetch, Chief Investment Officer and Executive Vice President, entered into a Rule 10b5-1 trading arrangement on September 1, 2026. Pursuant to the 10b5-1 plan, Mr. Keetch may make gifts of the Company's common stock having an aggregate value of up to $300 thousand between November 30, 2026 and December 31, 2026.
|
| Name | Chad A. Keetch |
| Title | Chief Investment Officer and Executive Vice President |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | September 1, 2026 |
| Expiration Date | December 31, 2026 |
| Arrangement Duration | 31 days |